Abstract
To determine the presence and extent of aortic valve calcification (AVC) quantified by non-contrast cardiac computed tomography (NCCT), to determine the association between traditional cardiovascular risk factors and AVC score, and to evaluate the association between AVC and cardiac size and function assessed by echocardiography, in a general population aged 65–75 years. A random sample of 2060 individuals were invited to undergo NCCT through which their AVC score was assessed. Individuals with an AVC score ≥ 300 arbitrary units (AU) were invited for a transthoracic echocardiography together with age-matched controls. Descriptive statistics and multiple regression analyses were performed to identify risk factors associated with AVC and to describe associations between AVC score and echocardiographic findings. Of 2060 individuals invited 664 males and 636 females participated. Among those, 455 (68.5%) of males and 358 (56.3%) of females had AVC scores > 0 AU. The median AVC score was 6 AU (IQR 0–3064). Seventy-seven (11.6%) males and 20 (3.1%) females had an AVC score ≥ 300 AU. In a multiple regression analysis, age, sex, prior cardiovascular disease, smoking, and hypertension were associated with AVC score, while diabetes, hypercholesterolemia and kidney function were not. Individuals with AVC ≥ 300 AU had higher peak and mean aortic valve gradient, smaller indexed aortic valve area, greater left ventricular mass, and larger left atrial (LA) volume. In a random population sample of individuals aged 65–75 years, AVC was common and associated with most known cardiovascular risk factors. AVC ≥ 300 AU was associated with concentric remodeling and LA dilatation.
Similar content being viewed by others
References
Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142–147. https://doi.org/10.1056/NEJM199907153410302
Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202. https://doi.org/10.1001/jama.289.2.194
Carabello BA, Paulus WJ (2009) Aortic stenosis. Lancet 373:956–966. https://doi.org/10.1016/S0140-6736(09)60211-7
Malaisrie SC, McDonald E, Kruse J, Li Z, McGee EC Jr, Abicht TO et al (2014) Mortality while waiting for aortic valve replacement. Ann Thorac Surg 98:1564–1570. https://doi.org/10.1016/j.athoracsur.2014.06.040
Chin CWL, Everett RJ, Kwiecinski J, Vesey AT, Yeung E, Esson G et al (2017) Myocardial fibrosis and cardiac decompensation in aortic stenosis. JACC Cardiovasc Imaging 10:1320–1333. https://doi.org/10.1016/j.jcmg.2016.10.007
Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB et al (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352:2389–2397. https://doi.org/10.1056/NEJMoa043876
O’Brien KD, Probstfield JL, Caulfield MT, Nasir K, Takasu J, Shavelle DM et al (2005) Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 165:858–862. https://doi.org/10.1001/archinte.165.8.858
Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K et al (2008) Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359:1343–1356. https://doi.org/10.1056/NEJMoa0804602
Innasimuthu AL, Katz WE (2011) Effect of bisphosphonates on the progression of degenerative aortic stenosis. Echocardiography 28:1–7. https://doi.org/10.1111/j.1540-8175.2010.01256.x
Teo KK, Corsi DJ, Tam JW, Dumesnil JG, Chan KL (2011) Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebo-controlled clinical trials on 2344 patients. Can J Cardiol 27:800–808. https://doi.org/10.1016/j.cjca.2011.03.012
Capoulade R, Chan KL, Mathieu P, Bosse Y, Dumesnil JG, Tam JW et al (2017) Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: results from the ASTRONOMER trial. Atherosclerosis 260:1–7. https://doi.org/10.1016/j.atherosclerosis.2017.03.013
Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S et al (2017) Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 30:372–392. https://doi.org/10.1016/j.echo.2017.02.009
Malouf J, Le Tourneau T, Pellikka P, Sundt TM, Scott C, Schaff HV et al (2012) Aortic valve stenosis in community medical practice: determinants of outcome and implications for aortic valve replacement. J Thorac Cardiovasc Surg 144:1421–1427. https://doi.org/10.1016/j.jtcvs.2011.09.075
Cueff C, Serfaty JM, Cimadevilla C, Laissy JP, Himbert D, Tubach F et al (2011) Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart 97:721–726. https://doi.org/10.1136/hrt.2010.198853
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ et al (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791. https://doi.org/10.1093/eurheartj/ehx391
Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M et al (2000) Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 343:611–617. https://doi.org/10.1056/NEJM200008313430903
Pawade T, Sheth T, Guzzetti E, Dweck MR, Clavel MA (2019) Why and how to measure aortic valve calcification in patients with aortic stenosis. JACC Cardiovasc Imaging 12:1835–1848. https://doi.org/10.1016/j.jcmg.2019.01.045
Diederichsen AC, Rasmussen LM, Sogaard R, Lambrechtsen J, Steffensen FH, Frost L et al (2015) The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial. Trials 16:554. https://doi.org/10.1186/s13063-015-1082-6
Kvist TV, Lindholt JS, Rasmussen LM, Sogaard R, Lambrechtsen J, Steffensen FH et al (2017) The DanCavas pilot study of multifaceted screening for subclinical cardiovascular disease in men and women aged 65-74 years. Eur J Vasc Endovasc Surg 53:123–131. https://doi.org/10.1016/j.ejvs.2016.10.010
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832. https://doi.org/10.1016/0735-1097(90)90282-t
Einstein AJ, Knuuti J (2012) Cardiac imaging: does radiation matter? Eur Heart J 33:573–578. https://doi.org/10.1093/eurheartj/ehr281
Paulsen NH, Carlsen BB, Dahl JS, Carter-Storch R, Christensen NL, Khurrami L et al (2016) Association between aortic valve calcification measured on non-contrast computed tomography and aortic valve stenosis in the general population. J Cardiovasc Comput Tomogr 10:309–315. https://doi.org/10.1016/j.jcct.2016.05.001
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270. https://doi.org/10.1093/ehjci/jev014
Stewart B, Siscovick D, Lind B, Gardin J, Gottdiener J, Smith V et al (1997) Clinical factors associated with calcific aortic valve disease. Cardiovasc Health Study J Am Coll Cardiol 29:630–634. https://doi.org/10.1016/s0735-1097(96)00563-3
Cosmi J, Kort S, Tunick P, Rosenzweig B, Freedberg R, Katz E et al (2002) The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med 162:2345–2347. https://doi.org/10.1001/archinte.162.20.2345
Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL et al (2006) Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 113:2113–2119. https://doi.org/10.1161/CIRCULATIONAHA.105.598086
Thanassoulis G, Massaro JM, Cury R, Manders E, Benjamin EJ, Vasan RS et al (2010) Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. J Am Coll Cardiol 55:2491–2498. https://doi.org/10.1016/j.jacc.2010.03.019
Kalsch H, Lehmann N, Mahabadi AA, Bauer M, Kara K, Huppe P et al (2014) Beyond Framingham risk factors and coronary calcification: does aortic valve calcification improve risk prediction? The Heinz Nixdorf Recall Study. Heart 100:930–937. https://doi.org/10.1136/heartjnl-2013-305205
Olsson M, Thyberg J, Nilsson J (1999) Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 19:1218–1222. https://doi.org/10.1161/01.atv.19.5.1218
Eckel R, Grundy S, Zimmet P (2005) The metabolic syndrome. Lancet 365:1415–1428. https://doi.org/10.1016/S0140-6736(05)66378-7
Messika-Zeitoun D, Aubry MC, Detaint D, Bielak LF, Peyser PA, Sheedy PF et al (2004) Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 110:356–362. https://doi.org/10.1161/01.CIR.0000135469.82545.D0
Clavel MA, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S et al (2014) Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol 64:1202–1213. https://doi.org/10.1016/j.jacc.2014.05.066
Yan AT, Koh M, Chan KK, Guo H, Alter DA, Austin PC et al (2017) Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study. J Am Coll Cardiol 69:1523–1532. https://doi.org/10.1016/j.jacc.2017.01.025
Danielsen R, Aspelund T, Harris TB, Gudnason V (2014) The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavik study. Int J Cardiol 176:916–922. https://doi.org/10.1016/j.ijcard.2014.08.053
Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG et al (2005) Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111:3290–3295. https://doi.org/10.1161/CIRCULATIONAHA.104.495903
Dahl JS, Christensen NL, Videbaek L, Poulsen MK, Carter-Storch R, Hey TM et al (2014) Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis. Circ Cardiovasc Imaging 7:142–148. https://doi.org/10.1161/CIRCIMAGING.113.000636
Christensen NL, Dahl JS, Carter-Storch R, Bakkestrom R, Jensen K, Steffensen FH et al (2016) Association between left atrial dilatation and invasive hemodynamics at rest and during exercise in asymptomatic aortic stenosis. Circ Cardiovasc Imaging. https://doi.org/10.1161/CIRCIMAGING.116.005156
Rusinaru D, Bohbot Y, Kowalski C, Ringle A, Marechaux S, Tribouilloy C (2017) Left atrial volume and mortality in patients with aortic stenosis. J Am Heart Assoc. https://doi.org/10.1161/JAHA.117.006615
Pawade T, Clavel MA, Tribouilloy C, Dreyfus J, Mathieu T, Tastet L et al (2018) Computed tomography aortic valve calcium scoring in patients with aortic stenosis. Circ Cardiovasc Imaging 11:e007146. https://doi.org/10.1161/CIRCIMAGING.117.007146
Clavel MA, Messika-Zeitoun D, Pibarot P, Aggarwal SR, Malouf J, Araoz PA et al (2013) The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. J Am Coll Cardiol 62:2329–2338. https://doi.org/10.1016/j.jacc.2013.08.1621
Acknowledgements
The study was supported by grants from the Center for Individualized Medicine in Arterial disease (CIMA), University of Southern Denmark, and the Region of Southern Denmark. Special thanks go to Dr. MH Fredgart for performing the scans for inter- and intraobserver variability and aiding with the calculations of scores.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Written and oral informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Khurrami, L., Møller, J.E., Dahl, J.S. et al. The association between aortic valve calcification, cardiovascular risk factors, and cardiac size and function in a general population. Int J Cardiovasc Imaging 37, 711–722 (2021). https://doi.org/10.1007/s10554-020-02012-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-020-02012-2